Immunovant Inc reports results for the quarter ended in June - Earnings Summary

Immunovant

10/08/2023 13:49

* Immunovant Inc  IMVT.OQ  reported a quarterly adjusted
loss
of 57 cents​​ per share for the quarter ended in June. The mean
expectation of twelve analysts for the quarter was for a loss
of 45 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Immunovant Inc's reported EPS for the quarter was a loss
of 57
cents​.
    * The mean earnings estimate of analysts had risen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Immunovant Inc shares had risen by 10.3% this quarter and
gained 17.9% so far this year.
    * The company reported a quarterly loss of $73.94 million.
    * Wall Street's median 12-month price target for Immunovant
Inc is
$30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 12:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.45          -0.57          Missed
 Mar. 31 2023      -0.43          -0.46          Missed
 Dec. 31 2022      -0.39          -0.49          Missed
 Sep. 30 2022      -0.39          -0.41          Missed